- Home
- WLDS vs APVO Comparison
WLDS vs APVO Comparison
Compare WLDS & APVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WLDS
- APVO
- Stock Information
- Founded
- WLDS 2014
- APVO 2016
- Country
- WLDS Israel
- APVO United States
- Employees
- WLDS N/A
- APVO N/A
- Industry
- WLDS Computer Communications Equipment
- APVO Biotechnology: Pharmaceutical Preparations
- Sector
- WLDS Telecommunications
- APVO Health Care
- Exchange
- WLDS Nasdaq
- APVO Nasdaq
- Market Cap
- WLDS 19.7M
- APVO 21.7M
- IPO Year
- WLDS 2022
- APVO N/A
- Fundamental
- Price
- WLDS $1.81
- APVO $1.48
- Analyst Decision
- WLDS
- APVO
- Analyst Count
- WLDS 0
- APVO 0
- Target Price
- WLDS N/A
- APVO N/A
- AVG Volume (30 Days)
- WLDS 506.8K
- APVO 990.5K
- Earning Date
- WLDS 12-09-2025
- APVO 11-06-2025
- Dividend Yield
- WLDS N/A
- APVO N/A
- EPS Growth
- WLDS N/A
- APVO N/A
- EPS
- WLDS N/A
- APVO N/A
- Revenue
- WLDS $422,000.00
- APVO N/A
- Revenue This Year
- WLDS N/A
- APVO N/A
- Revenue Next Year
- WLDS N/A
- APVO N/A
- P/E Ratio
- WLDS N/A
- APVO N/A
- Revenue Growth
- WLDS N/A
- APVO N/A
- 52 Week Low
- WLDS $1.00
- APVO $1.32
- 52 Week High
- WLDS $11.92
- APVO $298.00
- Technical
- Relative Strength Index (RSI)
- WLDS 31.22
- APVO 46.10
- Support Level
- WLDS $2.51
- APVO $1.40
- Resistance Level
- WLDS $2.69
- APVO $1.53
- Average True Range (ATR)
- WLDS 0.28
- APVO 0.08
- MACD
- WLDS -0.08
- APVO 0.01
- Stochastic Oscillator
- WLDS 2.13
- APVO 38.64
About WLDS Wearable Devices Ltd.
Wearable Devices Ltd develops and sells human-machine interface solutions for the smart wearables industry. These digital devices include consumer electronics, smart watches, smartphones, AR glasses, VR headsets, televisions, PCs, laptop computers, drones, robots, etc. The company has completed the transition phase from research and development to commercialization of technology into B2B and B2C products. Its products include Mudra Inspire, a band for the Apple Watch that allows touchless operation and control of Apple ecosystem devices such as iPhone, Mac computer, Apple TV, and iPad, inter alia.
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.